Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of pima indians

Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508

Molecular and Cellular Aspects of the Insulin-Like Growth Factor I Receptor

LeRoith, D., Werner, H., Beitner‐Johnson, D., & Roberts, C. T. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-2-143 · Cited by 1,424

Normal growth and development in the absence of hepatic insulin-like growth factor I

Yakar, S., Liu, J., STANNARD, B. S., Butler, A. A., Accili, D., Sauer, B., & LeRoith, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7324 · Cited by 1,418

Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction.

Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296

Quantitation of Muscle Glycogen Synthesis in Normal Subjects and Subjects with Non-Insulin-Dependent Diabetes by13C Nuclear Magnetic Resonance Spectroscopy

Shulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248

A Muscle-Specific Insulin Receptor Knockout Exhibits Features of the Metabolic Syndrome of NIDDM without Altering Glucose Tolerance

Brüning, J. C., Michael, M. D., Winnay, J. N., Hayashi, T., Hörsch, D., Accili, D., Goodyear, L. J., & Kahn, C. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80155-0 · Cited by 1,173

Tissue-Specific Knockout of the Insulin Receptor in Pancreatic β Cells Creates an Insulin Secretory Defect Similar to that in Type 2 Diabetes

Kulkarni, R., Brüning, J. C., Winnay, J. N., Postic, C., Magnuson, M. A., & Kahn, C. R. (1999) · Cell · doi:10.1016/s0092-8674(00)80546-2 · Cited by 1,148

Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance

Zisman, A., Peroni, O. D., Abel, E. D., Michael, M. D., Mauvais-Jarvis, F., Lowell, B. B., Wojtaszewski, J. F. P., Hirshman, M. F., Virkamaki, A., Goodyear, L. J., et al. (2000) · Nature Medicine · doi:10.1038/78693 · Cited by 743

Untitled work

(1997) · Diabetes reviews · Cited by 671

Early neonatal death in mice homozygous for a null allele of the insulin receptor gene

Accili, D., Drago, J., Lee, E. J., Johnson, M. D., Cool, M. H., Salvatore, P., Asico, L. D., José, P. A., Taylor, S. I., & Westphal, H. (1996) · Nature Genetics · doi:10.1038/ng0196-106 · Cited by 594

High‐frequency electrically stimulated skeletal muscle contractions increase p70s6k phosphorylation independent of known IGF‐I sensitive signaling pathways

Witkowski, S., Lovering, R. M., & Spangenburg, E. E. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.05.003 · Cited by 34

Angiotensin II-Induced Insulin Resistance Is Enhanced in Adrenomedullin-Deficient Mice

Xing, G., Shimosawa, T., Ogihara, T., Matsui, H., Itakura, K., Xu, Q., Asano, T., Ando, K., & Fujita, T. (2004) · Endocrinology · doi:10.1210/en.2004-0027 · Cited by 31

Insulin growth factor binding proteins as therapeutic targets in type 2 diabetes

Hjortebjerg, R., Flyvbjerg, A., & Frystyk, J. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.858698 · Cited by 30

EMT reversal in human cancer cells after IR knockdown in hyperinsulinemic mice

Zelenko, Z., Gallagher, E. J., Antoniou, I. M., Sachdev, D., Nayak, A., Yee, D., & LeRoith, D. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0142 · Cited by 30

Investigating New Therapeutic Strategies Targeting Hyperinsulinemia's Mitogenic Effects in a Female Mouse Breast Cancer Model

Rostoker, R., Bitton-Worms, K., Caspi, A., Shen‐Orr, Z., & LeRoith, D. (2013) · Endocrinology · doi:10.1210/en.2012-2263 · Cited by 29

Effects of theFTOGene on Lifestyle Intervention Studies in Children

Rendo‐Urteaga, T., Moleres, A., & del Moral, A. M. (2009) · Obesity Facts · doi:10.1159/000262296 · Cited by 27

GLUT4-overexpressing engineered muscle constructs as a therapeutic platform to normalize glycemia in diabetic mice

Beckerman, M., Harel, C., Michael, I., Klip, A., Bilan, P. J., Gallagher, E. J., LeRoith, D., Lewis, E. C., Karnieli, E., & Levenberg, S. (2021) · Science Advances · doi:10.1126/sciadv.abg3947 · Cited by 28

Polyol accumulation in muscle and liver in a mouse model of type 2 diabetes

Gallagher, E. J., LeRoith, D., Stasinopoulos, M., Zelenko, Z., & Shiloach, J. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.04.019 · Cited by 28

Prolonged insulin treatment sensitizes apoptosis pathways in pancreatic β cells

Bucris, E. D., Beck, A., Boura‐Halfon, S., Isaac, R., Vinik, Y., Rosenzweig, T., Sampson, S. R., & Zick, Y. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0505 · Cited by 29

Liver-specific IGF-I gene deficient mice exhibit accelerated diabetes in response to streptozotocin, associated with early onset of insulin resistance

Yu, R. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(03)00145-x · Cited by 28

MKR mice have increased dynamic glucose disposal despite metabolic inflexibility, and hepatic and peripheral insulin insensitivity

Vaitheesvaran, B., LeRoith, D., & Kurland, I. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1827-4 · Cited by 27

Deletion of Growth Hormone Receptors in Postnatal Skeletal Muscle of Male Mice Does Not Alter Muscle Mass and Response to Pathological Injury

Vijayakumar, A., Buffin, N. J., Gallagher, E. J., Blank, J., Wu, Y., Yakar, S., & LeRoith, D. (2013) · Endocrinology · doi:10.1210/en.2013-1209 · Cited by 28

Diabetic nephropathy in a nonobese mouse model of Type 2 diabetes mellitus

Mallipattu, S. K., Gallagher, E. J., LeRoith, D., Liu, R., Mehrotra, A., Horne, S. J., Chuang, P. Y., Yang, V. W., & He, C. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00597.2013 · Cited by 27

In Vivo Mutagenesis of the Insulin Receptor

Okamoto, H., & Accili, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.r300009200 · Cited by 27

Intestinal microbiota regulates diabetes and cancer progression by IL-1β and NOX4 dependent signaling cascades

Noureldein, M. H., Nawfal, R., Bitar, S., Maxwell, S., Khurana, I., Kassouf, H. K., Khuri, F. R., El‐Osta, A., & Eid, A. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04485-x · Cited by 29

Apolipoprotein E deficiency abrogates insulin resistance in a mouse model of type 2 diabetes mellitus

Kawashima, Y., Chen, J., Sun, H., Lann, D. E., Hajjar, R. J., Yakar, S., & LeRoith, D. (2009) · Diabetologia · doi:10.1007/s00125-009-1378-8 · Cited by 27

Role of Altered Metabolic Microenvironment in Osteolytic Metastasis

Tiedemann, K., Hussein, O., & Komarova, S. V. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00435 · Cited by 24

IGF-I stimulates reactive oxygen species (ROS) production and inhibits insulin-dependent glucose uptake via ROS in 3T3-L1 adipocytes

Fukuoka, H., Iida, K., Nishizawa, H., Imanaka, M., Takeno, R., Iguchi, G., Takahashi, M., Okimura, Y., Kaji, H., Chihara, K., et al. (2010) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2010.02.001 · Cited by 25

Diabetes, Insulin and Alzheimer's Disease

Craft, S., & Christen, Y. (2010) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-642-04300-0 · Cited by 24

Inactivation of muscle insulin and IGF-I receptors and insulin responsiveness

Roith, D. L., Kim, H., Fernandez, A. M., & Accili, D. (2002) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200207000-00004 · Cited by 24

Metformin regulates bone marrow stromal cells to accelerate bone healing in diabetic mice

Guo, Y., Wei, J., Liu, C.-J., Li, X., & Yan, W. (2023) · eLife · doi:10.7554/elife.88310 · Cited by 25

Does IGF-I stimulate pancreatic islet cell growth?

Liu, J. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0016-7 · Cited by 22

Plasma relaxin concentration is related to beta-cell function and insulin sensitivity in women with type 2 diabetes mellitus

Szepietowska, B., Górska, M., & Szelachowska, M. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.10.017 · Cited by 22

Viral expression of insulin-like growth factor I E-peptides increases skeletal muscle mass but at the expense of strength

Brisson, B. K., Spinazzola, J. M., Park, S.-H., & Barton, E. R. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00008.2014 · Cited by 23

Growth hormone signaling in pancreatic β-cells—Calcium handling regulated by growth hormone

Zhang, F., Sjöholm, Å., & ZHANG, Q. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.06.001 · Cited by 21

The midlife transition and the risk of cardiovascular disease and cancer Part I: magnitude and mechanisms

KASE, N. G., Friedman, E. G., Brodman, M. L., Kang, C., Gallagher, E. J., & LeRoith, D. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.05.051 · Cited by 24

A review on associated factors and management measures for sarcopenia in type 2 diabetes mellitus

Zhang, Y., Zhang, K., Huang, S., Li, W., & He, P. (2024) · Medicine · doi:10.1097/md.0000000000037666 · Cited by 26

The beta-3 adrenergic agonist (CL-316,243) restores the expression of down-regulated fatty acid oxidation genes in type 2 diabetic mice

Kumar, A., Shiloach, J., Betenbaugh, M. J., & Gallagher, E. J. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0003-8 · Cited by 21

Metabolic actions of the growth hormone-insulin growth factor-1 axis and its interaction with the central nervous system

Al–Massadi, O., Parini, P., Fernø, J., Luquet, S. H., & Quiñones, M. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09732-x · Cited by 23

Non‐Obese MKR Mouse Model of Type 2 Diabetes Reveals Skeletal Alterations in Mineralization and Material Properties

Tice, M., Bailey, S., Sroga, G. E., Gallagher, E. J., & Vashishth, D. (2021) · JBMR Plus · doi:10.1002/jbm4.10583 · Cited by 20

Functional Interaction Between SNPs and Microsatellite in the Transcriptional Regulation of Insulin-Like Growth Factor 1

Chen, H. Y., Huang, W., Leung, V. H. K., Fung, S. L. M., Ma, S. L., Jiang, H., & Tang, N. L. S. (2013) · Human Mutation · doi:10.1002/humu.22363 · Cited by 19

Can endogenous hyperinsulinaemia explain the increased risk of cancer development and mortality in type 2 diabetes: evidence from mouse models

LeRoith, D. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1139 · Cited by 18

IGF1R is a mediator of sex-specific metabolism in mice: Effects of age and high-fat diet

Pérez‐Matute, P., López, I. P., Íñiguez, M., Recio‐Fernández, E., Torrens, R., Piñeiro‐Hermida, S., Alfaro‐Arnedo, E., Chau, L., Walz, C., Hoeflich, A., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1033208 · Cited by 18

The Aryl Hydrocarbon Receptor Relays Metabolic Signals to Promote Cellular Regeneration

Casado, F. L. (2016) · Stem Cells International · doi:10.1155/2016/4389802 · Cited by 18

Long-term treatment with the ghrelin receptor antagonist [ d -Lys3]-GHRP-6 does not improve glucose homeostasis in nonobese diabetic MKR mice

Mosa, R., Huang, L., Li, H., Grist, M., LeRoith, D., & Chen, C. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00157.2017 · Cited by 18

The effect of rs9939609 FTO gene polymorphism on weight loss after laparoscopic sleeve gastrectomy

Balasar, Ö., Çakır, T., Erkal, Ö., Aslaner, A., Çekiç, B., Uyar, M., Bülbüller, N., & Oruç, M. T. (2015) · Surgical Endoscopy · doi:10.1007/s00464-015-4169-y · Cited by 18

Is insulin-like growth factor 1 (IGF-1) system an attractive target inflammatory bowel diseases? Benefits and limitation of potential therapy

Zatorski, H., Marynowski, M., & Fichna, J. (2016) · Pharmacological Reports · doi:10.1016/j.pharep.2016.03.006 · Cited by 19

Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups

Shah, U. A., Moshier, E. L., Derkach, A., Huang, Y., Mailankody, S., Tan, C. R. C., Maclachlan, K. H., Hultcrantz, M. L., Korde, N., Hassoun, H., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010815 · Cited by 17

Metformin Improves Diabetic Bone Health by Re-Balancing Catabolism and Nitrogen Disposal

Li, X., Guo, Y., Yan, W., Snyder, M. P., & Li, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0146152 · Cited by 17

Insulin-like growth factor role in determining the anti-cancer effect of metformin: RCT in prostate cancer patients

Birzniece, V., Lam, T., McLean, M. P., Reddy, N., Shahidipour, H., Hayden, A. J., Gurney, H., Stone, G., Hjortebjerg, R., & Frystyk, J. (2022) · Endocrine Connections · doi:10.1530/ec-21-0375 · Cited by 16

Microbiota- Brain-Gut-Axis Relevance to Parkinson’s Disease: Potential Therapeutic Effects of Probiotics

Raj, K., Singh, S., Chib, S., & Mallan, S. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666221003112300 · Cited by 16

OP449 inhibits breast cancer growth without adverse metabolic effects

Shlomai, G., Zelenko, Z., Antoniou, I. M., Stasinopoulos, M., Tobin‐Hess, A., Vitek, M. P., LeRoith, D., & Gallagher, E. J. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0077 · Cited by 16

Muscle-Specific Insulin Receptor Overexpression Protects Mice From Diet-Induced Glucose Intolerance but Leads to Postreceptor Insulin Resistance

Wang, G., Yu, Y., Cai, W., Batista, T. M., Suk, S., Noh, H. L., Hirshman, M. F., Nigro, P., Li, M. E., Softic, S., et al. (2020) · Diabetes · doi:10.2337/db20-0439 · Cited by 16

Reduction of adiposity with prolonged growth hormone treatment in old obese rats: effects on glucose handling and early insulin signaling

Johansen, T., Laurino, C., Barreca, A., & Malmlöf, K. (2005) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2004.11.006 · Cited by 16

Multi-Tissue Computational Modeling Analyzes Pathophysiology of Type 2 Diabetes in MKR Mice

Kumar, A., Harrelson, T. F., Lewis, N. E., Gallagher, E. J., LeRoith, D., Shiloach, J., & Betenbaugh, M. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102319 · Cited by 16

Role of genetic variation in insulin-like growth factor 1 receptor on insulin resistance and arterial hypertension

Sookoian, S. C., Gianotti, T. F., Gemma, C., Burgueño, A. L., & Pirola, C. J. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328337f6d5 · Cited by 16

Anti-inflammatory action of insulin via induction of Gadd45-β transcription by the mTOR signaling pathway

Messina, J. L. (2010) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s7083 · Cited by 15

Novel Paracrine Action of Endothelium Enhances Glucose Uptake in Muscle and Fat

Viswambharan, H., Yuldasheva, N. Y., Imrie, H., Bridge, K., Haywood, N. J., Skromna, A., Hemmings, K. E., Clark, E. R., Gatenby, V. K., Cordell, P. A., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.319517 · Cited by 15

Growth Hormone, Insulin-Like Growth Factor I, and Growth: Local Knowledge

Frank, S. J. (2007) · Endocrinology · doi:10.1210/en.2007-0064 · Cited by 15

Role of CaMKII in diabetes induced vascular injury and its interaction with anti-diabetes therapy

Chacar, S., Abdi, A. M., Almansoori, K., Alshamsi, J., Hageh, C. A., Zalloua, P., Khraibi, A. A., Holt, S. G., & Nader, M. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09855-9 · Cited by 13

Growth hormone can improve insulin resistance and differentiation in pancreas of senescence accelerated prone male mice (SAMP8)

Cuesta‐Sancho, S., Kireev, R. A., Forman, K., Garcı́a, C., Acuña-Castroviejo, D., Vara, E., & Tresguerres, J. A. F. (2011) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2010.12.007 · Cited by 14

Ovariectomy is associated with metabolic impairments and enhanced mammary tumor growth in MKR mice

Ben-Shmuel, S., Scheinman, E. J., Rashed, R., Orr, Z. S., Gallagher, E. J., LeRoith, D., & Rostoker, R. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0310 · Cited by 15

RNA-binding protein GIGYF2 orchestrates hepatic insulin resistance through STAU1/PTEN-mediated disruption of the PI3K/AKT signaling cascade

Lv, Z., Ren, Y., Li, Y., Niu, F., Li, Z., Li, M., Li, X., Li, Q., Huang, D.-Q., Yu, Y., et al. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00889-6 · Cited by 13

Zuogui Jiangtang Shuxin formula Ameliorates diabetic cardiomyopathy mice via modulating gut-heart axis

Huang, Y., Qin, X., Zou, J., Wu, Y., & Yu, R. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1106812 · Cited by 13

Liver Kinase B1 Expression Promotes Phosphatase Activity and Abrogation of Receptor Tyrosine Kinase Phosphorylation in Human Cancer Cells

Okon, I. S., Coughlan, K. A., & Zou, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.500934 · Cited by 11

Lack of miR-379/miR-544 Cluster Resists High-Fat Diet-Induced Obesity and Prevents Hepatic Triglyceride Accumulation in Mice

Cao, C., Duan, P., Li, W., Guo, Y., Zhang, J., Gui, Y., & Yuan, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.720900 · Cited by 12

The IGF and IGFBP System in Insulin Resistance and Diabetes Mellitus

Brismar, K., & LEWITT, M. S. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-795-6_14 · Cited by 12

Functionalized gadofullerene ameliorates impaired glycolipid metabolism in type 2 diabetic mice

Wu, J. C., Chen, Y., Li, X., Ran, L., Liu, X., Wang, X., Zhen, M., Shao, S., Zeng, L., Wang, C., et al. (2021) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.09.004 · Cited by 11

Hyperinsulinemia induces early and dyssynchronous puberty in lean female mice

Saleh, F., Joshi, A. A., Tal, A., Xu, P., Hens, J. R., Wong, S. L., & Flannery, C. A. (2022) · Journal of Endocrinology · doi:10.1530/joe-21-0447 · Cited by 11

Reduced skeletal muscle AMPK and mitochondrial markers do not promote age-induced insulin resistance

Bujak, A. L., Blümer, R. M. E., Marcinko, K., Fullerton, M. D., Kemp, B. E., & Steinberg, G. R. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01101.2013 · Cited by 12

Hexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in Nonobese Insulin-Resistant Male MKR Mice

Mosa, R., Huang, L., Wu, Y., Fung, C., Mallawakankanamalage, O., LeRoith, D., & Chen, C. (2017) · Endocrinology · doi:10.1210/en.2017-00168 · Cited by 11

Inhibitor of myogenic differentiation family isoform a, a new positive regulator of fibronectin production by glomerular mesangial cells

Shotorbani, P. Y., Chaudhari, S. K., Tao, Y., Tsiokas, L., & Ma, R. (2020) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00508.2019 · Cited by 11

Maternal Low-Fat Diet Programs the Hepatic Epigenome despite Exposure to an Obesogenic Postnatal Diet

Moody, L., Shao, J., Chen, H., & Pan, Y. (2019) · Nutrients · doi:10.3390/nu11092075 · Cited by 11

Mechanisms of protein degradation in atrophying muscles: What have we learned during the past decade?

Shemer, S. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111229 · Cited by 11

Sarcopenia in the setting of nonalcoholic fatty liver

Arrese, M. A., Cabello‐Verrugio, C., Arab, J. P., Francisco Barrera, M., Baudrand, R. F., Guarda, F. J., Gul, I., & Cabrera, D. (2022) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2021.16 · Cited by 10

Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes

Gallagher, E. J., Zelenko, Z., Tobin‐Hess, A., Ulrich, W., Tennagels, N., & LeRoith, D. (2016) · Diabetologia · doi:10.1007/s00125-016-4000-x · Cited by 10

An Integrative Pharmacology-Based Strategy to Uncover the Mechanism of Zuogui Jiangtang Shuxin Formula in Diabetic Cardiomyopathy

Huang, Y., Zhang, Y., Wu, Y., Qin, X., & Yu, R. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s390883 · Cited by 10

Identification and functional analysis of a novel G310D variant in the insulin‐like growth factor 1 receptor (IGF1R) gene associated with type 2 diabetes in A merican I ndians

Muller, Y. L., Skelton, G., Piaggi, P., Chen, P., Nair, A. K., Kobes, S., Hsueh, W., Knowler, W. C., Hanson, R. L., Baier, L. J., et al. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2994 · Cited by 10

Two Types of Mouse Models for Sarcopenia Research: Senescence Acceleration and Genetic Modification Models

Baek, K., Jung, Y., Park, J. S., Kim, J., Hah, Y., Kim, S.-J., & Yoo, J. (2021) · Journal of Bone Metabolism · doi:10.11005/jbm.2021.28.3.179 · Cited by 10

Circulation Free Leptin in Diabetic Patients and its Correlation to Insulin Level

Mohiti, J., Talebi, F., & Afkhami-Ar, M. (2009) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2009.397.400 · Cited by 10

A GC-MS-Based Metabolomics Investigation of the Protective Effect of Liu-Wei-Di-Huang-Wan in Type 2 Diabetes Mellitus Mice

Huang, J., He, D., Chen, L., Du, Q., Yu, R., Cai, P., & Zhang, S. (2020) · International Journal of Analytical Chemistry · doi:10.1155/2020/1306439 · Cited by 9

A novel SUCNR1 inhibitor alleviates dysbiosis through inhibition of host responses without direct interaction with host microbiota

Thomas, S. C., Guo, Y., Xu, F., Saxena, D. B., & Li, X. (2023) · Molecular Oral Microbiology · doi:10.1111/omi.12431 · Cited by 8

Skeletal Muscle

Fernandez, A. M., & LeRoith, D. (2005) · Springer eBooks · doi:10.1007/0-387-26274-1_5 · Cited by 8

Erratum to: Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes

Gallagher, E. J., Zelenko, Z., Tobin‐Hess, A., Ulrich, W., Tennagels, N., & LeRoith, D. (2017) · Diabetologia · doi:10.1007/s00125-017-4225-3 · Cited by 8

Transcriptional heterogeneity in human diabetic foot woundsPreprint

Sandoval-Schaefer, T., Phan, Q. M., Dash, B. C., Prassinos, A., Duan, K., Gazes, M. I., Vyce, S. D., Driskell, R. R., Hsia, H. C., & Horsley, V. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.16.528839 · Cited by 8

Nutrition‐/diet‐induced changes in gene expression in pancreatic β‐cells

Chadt, A., Yeo, G. S. H., & Al‐Hasani, H. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01640.x · Cited by 7

IGF-1 receptor haploinsufficiency leads to age-dependent development of metabolic syndrome

Thakur, S., Garg, N., Zhang, N., Hussey, S. E., Musi, N., & Adamo, M. L. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.129 · Cited by 7

Sensitivity of pituitary gonadotropes to hyperglycemia leads to epigenetic aberrations and reduced follicle‐stimulating hormone levels

Feldman, A., Saleh, A., Pnueli, L., Qiao, S., Shlomi, T., Boehm, U., & Melamed, P. (2018) · The FASEB Journal · doi:10.1096/fj.201800943r · Cited by 6

Deletion of muscle Igf1 exacerbates disuse atrophy weakness in mice

Spradlin, R. A., Vassilakos, G., Matheny, M. K., Jones, N. C., Goldman, J., Lei, H., & Barton, E. R. (2021) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00090.2021 · Cited by 8

Inter-organ steroid hormone signaling promotes myoblast fusion via direct transcriptional regulation of a single key effector gene

Ruan, Z.-R., Yu, Z., Xing, C., & Chen, E. H. (2024) · Current Biology · doi:10.1016/j.cub.2024.02.056 · Cited by 7

MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR mice

Bhattacharjee, A., Allister, E. M., & Wheeler, M. B. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-039 · Cited by 7

IUGR with catch-up growth programs impaired insulin sensitivity through LRP6/IRS-1 in male rats

Long, W., Zhou, T., Xuan, X., Cao, Q., Luo, Z., Qin, Y., Ning, Q., Luo, X., & Xie, X. (2021) · Endocrine Connections · doi:10.1530/ec-21-0203 · Cited by 8

Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle

Fernandez, A. M., Dupont, J., Farrar, R. P., Lee, S., STANNARD, B. S., & Roith, D. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200213503 · Cited by 7

Mechanism of Insulin Action

White, M. F. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch8 · Cited by 8

Antidiabetic Activity

Vogel, H. G. (2007) · Springer eBooks · doi:10.1007/978-3-540-70995-4_12 · Cited by 6

CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy

Rostoker, R., Ben-Shmuel, S., Rashed, R., Orr, Z. S., & LeRoith, D. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0711-7 · Cited by 6

Tissue-Specific Targeting of the Insulin Receptor Gene

Kulkarni, R., & Okada, T. (2002) · Endocrine · doi:10.1385/endo:19:3:257 · Cited by 6

Myostatin inhibits insulin‐like growth factor 1–dependent citrate secretion and osteogenesis via nicotinamide adenine dinucleotide phosphate oxidase‐4 in a mouse mesenchymal stem cell line

Liu, X., Pan, J. P., Bauman, W. A., & Cardozo, C. P. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14894 · Cited by 5

Effects of hyperthyroidism and diabetes mellitus on spermatogenesis in peri- and post-pubertal mice

Shi, H., Korejo, N. A., Kamboh, A. A., Korejo, R. A., & Shi, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1191571 · Cited by 5

Tissue IGF-I Measured by Microdialysis Reflects Body Glucose Utilization After rhIGF-I Injection in Type 1 Diabetes

Ekström, K., Pulkkinen, M., Carlsson‐Skwirut, C., Brorsson, A. L., Ma, Z., Frystyk, J., & Bang, P. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2070 · Cited by 5

Insulin-like Growth Factor (IGF) Receptor

Chan, S. (2007) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.60361-7 · Cited by 5

Muscle insulin-like growth factor-I modulates murine craniofacial bone growth

Kok, H. J., Crowder, C., Chee, L. K. M., Choi, H., Lin, N., & Barton, E. (2021) · European Cells and Materials · doi:10.22203/ecm.v042a06 · Cited by 4

Unraveling the mysteries of hepatic insulin signaling: deconvoluting the nuclear targets of insulin

Kitamoto, T., & Accili, D. (2023) · Endocrine Journal · doi:10.1507/endocrj.ej23-0150 · Cited by 4

Loss of Skeletal Muscle Inositol Polyphosphate Multikinase Disrupts Glucose Regulation and Limits Exercise Capacity

Lee, J.-H., Jung, I., Tu‐Sekine, B., Jin, S., Anokye‐Danso, F., Ahima, R. S., & Kim, S. F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062395 · Cited by 5

Role of Counterregulatory Hormones for Glucose Metabolism in Children and Adolescents with Type 1 Diabetes

Nishimura, A., Kobayashi, K., Yagasaki, H., Saito, T., Nagamine, K., Mitsui, Y., Mochizuki, M., Satoh, K., Kobayashi, K., Sano, T., et al. (2011) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.20.73 · Cited by 3

Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer’s Disease

Bonds, J. A., Hart, P. C., Minshall, R. D., Lazarov, O., Haus, J. M., & Bonini, M. G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802851-3.00013-9 · Cited by 3

Aging and the Metabolic Syndrome

Ruiz-Torres, A. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50005-x · Cited by 2

Animal Models of Hyperinsulinemia, Insulin Resistance, and Cancer

Novosyadlyy, R., Vijayakumar, A., Fierz, Y., & LeRoith, D. (2011) · Energy balance and cancer · doi:10.1007/978-1-4419-9911-5_6 · Cited by 3

The Role of IGF-1 and Hormone Binding Proteins in Understanding Insulin-Associated Equine Laminitis

Nanayakkara, S. N. (1905) · Queensland University of Technology · doi:10.5204/thesis.eprints.118300 · Cited by 3

Associations of IGF-1 and IGFBP-3 with Aging and the Development of Age-Associated Diseases

Константиновна, И. А., Matchekhina, L. V., Melnitskaia, A. A., & Strazhesko, I. D. (2024) · Advances in Gerontology · doi:10.1134/s2079057025600041 · Cited by 2

Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue

Lauro, D., Kido, Y., Castle, A. L., Zarnowski, M. J., Hayashi, H., Ebina, Y., & Accili, D. (1998) · Nature Genetics · doi:10.1038/3112 · Cited by 140

Type 2 diabetes in MKR transgenic mice caused by skeletal muscle-specific double deficiency of IGF-1 and insulin receptors

Hu, W. (2008) · Zhongguo tangniaobing zazhi

Inactivation of muscle insulin and IGF-I receptors and insulin responsiveness

Roith, D. L., Kim, H., Fernandez, A. M., & Accili, D. (2002) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200207000-00004 · Cited by 24

Mouse models of insulin resistance

Hribal, M. L., Oriente, F., & Accili, D. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00561.2001 · Cited by 251

Contributions of insulin resistance and release to the pathogenesis of type 2 diabetes in the MKR mouse

Shyr, Z. A. (2004) · TSpace (University of Toronto)